In vivo genome-wide CRISPR screens identify SOCS1 as intrinsic checkpoint of CD4 + T H 1 cell response
Nom de la revue
Science Immunology
Abstract
Inactivation of SOCS1 optimizes adoptive T cell therapy including human CAR-T cell composition and efficacy.